• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number VBHR080502A
Device Problem Material Separation (1562)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/24/2019
Event Type  malfunction  
Manufacturer Narrative
The review of the manufacturing paperwork verified that the lot met all pre-release specifications.
 
Event Description
On (b)(6) 2019, the patient was implanted with gore® viabahn® endoprostheses.It was reported the physician had dual access with two 12fr dryseal sheaths on the patients left side.It was reported the gore® viabahn® endoprostheses were implanted in the patient¿s left common iliac artery using a kissing technique.One (11x5) viabahn device was implanted retrograde from the groin.This device extended into the external iliac.A second (8x10) viabahn device was implanted antegrade from the axillary.This device reportedly extended into the internal iliac.The physician then placed a (9x15) viabahn device through the (8x10) viabahn device extending further into the internal artery.It was reported during extension of the (8x10) viabahn device into the common iliac artery a (8x5) viabahn device was advanced from the axillary sheath without issue into the (8x10) viabahn device in the common iliac.The physician deployed the stent fully.It was reported the deployment line broke at the hub of the catheter.The catheter was then removed without incident.There was reportedly no adverse events to the patient.
 
Manufacturer Narrative
Engineering evaluation states, based on the evaluation of the device, the following observations were made: no anomalies or non-routine maintenance were identified that could be attributed to the failure seen in this event.Therefore, based off of the evaluation performed, no manufacturing cause could be identified.Corrected conclusion code.
 
Manufacturer Narrative
Corrected g5 - combination product (yes).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9218950
MDR Text Key163309412
Report Number2017233-2019-01071
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00733132623303
UDI-Public00733132623303
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 01/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/06/2019
Device Catalogue NumberVBHR080502A
Device Lot Number16122360
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/09/2019
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age73 YR
-
-